國家衛生研究院 NHRI:数据类型相关文件

类别浏览

正在载入社群分类, 请稍候....

年代浏览

正在载入年代分类, 请稍候....

"meeting abstract"的相关文件

回到依数据类型浏览

显示 25 项.

显示项目1076-1100 / 1382. (共56页)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每页显示[10|25|50]项目

类别	日期	题名	關聯
[其他] 會議論文/會議摘要	2019-04	Long-term clinical outcomes of IMRT with simultaneous integrated boost for breast cancer	-
[劉滄梧] 會議論文/會議摘要	2017-05	Prevalence and estimated trend in chemotherapy use near death from population-based studies on cancer patients: A systematic review and meta-analysis	-
[劉玉麗] 會議論文/會議摘要	2019-01	Identifying variants in nf1a gene to be associated with seasonal pattern and susceptibility for depression through a candidate gene approach	-
[劉玉麗] 會議論文/會議摘要	2019-01	Distinct genetic profiles of peptic ulcer in individuals with depression	-
[劉玉麗] 會議論文/會議摘要	2019-01	Identification of genetic variants for suicidal behaviors in patients with bipolar or major depressive disorders	-
[姜乃榕] 期刊論文	2017-05	A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy	-
[常慧如] 會議論文/會議摘要	2017-05	Second malignant neoplasms in a nationwide population-based cohort of childhood cancer survivors in Taiwan	-
[張光裕] 會議論文/會議摘要	2018-07	Mitochondrial SOD2 is the mainstay to protect the stemness-featured glioblastoma cells against drug-induced reactive oxygen stress	-
[張光裕] 會議論文/會議摘要	2018-07	Sp1 acetylation associates with stemness characteristics in temozolomide-resistant glioblastoma	-
[張光裕] 會議論文/會議摘要	2018-07	Oleic acid promotes head and neck squamous cell carcinoma anoikis resistance and metastasis via ANGPTL4/fibronectin pathway	-
[施能耀] 會議論文/會議摘要	2018-07	Salt-inducible kinase 3 expression identifies long-term survivors of serous ovarian cancer	-
[松浦功] 會議論文/會議摘要	2018-07	Repression of CD44 expression by p53 in a breast cancer progression model	-
[楊良棟] 會議論文/會議摘要	2019-05	Gasdermin A3-mediated cell death causes niche collapse and precocious activation of hair follicle stem cells	-
[溫啟邦(2001-2010)] 會議論文/會議摘要	2018-10	Smokers with diabetes: Twice as deadly and shortened life by 15 years	-
[翁紹華] 會議論文/會議摘要	2018-07	4-Bromophenylhydrazinyl benzenesulfonylphenylureas inhibit indoleamine 2,3-dioxygenase in vitro and in vivo	-
[蔡世峯] 會議論文/會議摘要	2018-07	GATA3 mutation of luminal-type breast cancer patients in Taiwan	-
[謝興邦] 會議論文/會議摘要	2018-07	Clinical candidate DBPR112: A novel epidermal growth factor receptor inhibitor as a promising treatment for non-small cell lung cancer	-
[郭靜娟] 會議論文/會議摘要	2018-07	Blockage of EGFR signaling repurposes tumor metabolism through suppression of glycolysis and Kreb cycle in head and neck cancer	-
[陳立宗] 會議論文/會議摘要	2017-02	Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial	-
[陳立宗] 會議論文/會議摘要	2017-05	The prognostic value of baseline neutrophilto-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for predicting clinical outcome in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM	-
[陳立宗] 會議論文/會議摘要	2017-02	Characteristics of long-term survivors in a randomized phase III trial (NAPOLI-1) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM-398)+5-FU/LV	-
[陳立宗] 會議論文/會議摘要	2016-05	Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine	-
[陳立宗] 會議論文/會議摘要	2016-05	Effect of baseline carbohydrate antigen 19-9 (CA19-9) level on overall survival (OS) in NAPOLI-1: A randomized phase III study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine (gem)-based therapy	-
[陳立宗] 會議論文/會議摘要	2016-05	Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)	-
[陳立宗] 會議論文/會議摘要	2016-05	Quality-adjusted time without symptoms or toxicity (Q-TWiST) of nanoliposomal irinotecan (nal-IRI; MM-398) plus 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone in metastatic pancreatic adenocarcinoma (mPAC) patients (pts) previously treated with	-

数据加载中.....

类别浏览

年代浏览

"meeting abstract"的相关文件